Genus Shareholders’ Equity Growth & History (GNS)
Genus's shareholders’ equity was £766.7M for fiscal 2026.
View full Genus company overviewGenus annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | £766.7M | £290.6M | +61.04% |
| 2025 | 2025-06-30 | £476.1M | −£41.7M | −8.05% |
| 2024 | 2024-06-30 | £517.8M | −£26.7M | −4.90% |
| 2023 | 2023-06-30 | £544.5M | −£34.0M | −5.88% |
| 2022 | 2022-06-30 | £578.5M | — | — |
Genus quarterly shareholders’ equity
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | £504.0M | −£12.1M | −2.34% |
| Q4 2025 | 2025-06-30 | £475.6M | — | — |
| Q2 2025 | 2024-12-31 | £516.1M | — | — |
Genus shareholders’ equity trends
Between the periods ended 2022-06-30 and 2026-06-30, Genus's shareholders’ equity increased from £578.5M to £766.7M, a change of £188.2M. The latest reported quarter, Q2 2026, shows £504.0M.
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genus source filings ↗Community posts
Genus announces a £60 million buyback after stronger annual earnings
Genus ($GNS-LSE) announced a £60 million share-buyback program after adjusted pre-tax profit rose 35% to £100.2 million. Revenue declined 2% to £658.1 million, but stronger profitability in its pig-genetics business and improvements in its ...